Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
September 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
September 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Supplements
Adjunctive Lipid-Lowering Strategies for Patients Needing Additional LDL-C Lowering
Read More
The Role of Non-Statin Lipid-Lowering Therapy in Older Adults with ASCVD
Read More
Minimizing the Burden of Cardiovascular Disease: A Need for Lipid-Lowering Strategies Beyond Statins
Read More
Achieving Improved Outcomes Through Partnerships Between Optometrists and Retina Specialists
Read More
Faculty Perspectives
Advancing Anticoagulation Safety: Focus on Factor Xa Reversal
Read More
MOA Magnifier
Emerging Therapeutic Approaches to Treatment-Resistant Depression: Meeting Unmet Clinical Needs
Read More
March 2018, Supplement - Abemaciclib (Verzenio™), a Novel CDK4/6 Inhibitor, in the Treatment of Hormone Receptor–Positive, HER2-Negative Advanced Breast Cancer
Read More
A Multistakeholder Consensus on Challenges and Solutions to the Adoption of Biosimilars
Robert M. Rifkin, MD, FACP
,
Edward Li, PharmD, MPH, BCOP
,
Gillian Woollett, MA, DPhil
Read More
Value-Based Care
Value-Based Perspectives on the Management of Allergic Rhinitis
Eli O. Meltzer, MD
,
Don A. Bukstein, MD
,
Paul M. Hamrah, MS, PharmD
,
Nikkia Scott, PharmD
,
John A. Welz, MPH
Read More
Rx Profiler
Kevzara (Sarilumab): A Novel IL-6 Receptor Antagonist for Rheumatoid Arthritis
Read More
1
2
3
4
Page 1 of 6
Results 1 - 10 of 51